金山辦公(688111.SH)披露股東詢價轉讓結果:其中工銀瑞信受讓304.9萬股
格隆匯 12 月 11日丨金山辦公(688111.SH)披露股東詢價轉讓結果報告書,此次詢價轉讓的價格為300.08元/股,轉讓的股票數量為470萬股;
奇文五維持股比例由8.08%減少至7.82%;MS TMT Holding II Limited持股比例由5.21%減少至4.78%;紀源WPS持股比例由2.60%減少至2.38%;順為互聯網持股比例由1.30%減少至1.19%。

根據認購邀請書約定的定價原則,最終確認此次詢價轉讓價格為300.08元/股,6家投資者獲配,此次詢價轉讓結果如下:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.